GSP Crop Science files draft papers with SEBI to raise funds via IPO

Agrochemical Company, GSP Crop Science Ltd, has filed preliminary papers with the capital markets regulator SEBI to raise funds through an Initial Public Offering (IPO).

The Ahmedabad-based company's IPO is a mix of fresh issue of shares worth ₹280 crore and an Offer For Sale (OFS) of 60 lakh equity shares by promoters, according to the Draft Red Herring prospectus (DRHP).

The offer also includes a reservation for a subscription by employees.

The company may consider raising ₹56 crore as pre-IPO placement. If such placement is completed, the fresh issue size will be reduced.

As per the draft papers filed on Friday, proceeds from the fresh issue to the tune of ₹200 crore will be used for payment of debt and a portion will be utilised for general corporate purposes.

GSP Crop Science is a research-focused agrochemical company with over 39 years of expertise in developing and manufacturing insecticides, herbicides, fungicides, and plant growth regulators in India.

It provides crop protection solutions that help farmers maximize productivity and agricultural output by producing formulations—precisely composed products combining active ingredients (chemicals targeting pests, weeds, or diseases) and additives (enhancing performance, stability, and usability)—and Technicals, which are concentrated active ingredients used to create formulations.

As of September 30, 2024, the company had secured 507 registrations across Formulations and Technicals for agrochemicals manufactured, supported by a robust focus on research and development.

GSP Crop Science operates four manufacturing facilities located in Ahmedabad (Odhav and Kathwada), Vadodara (Nandesari), and Samba (Jammu & Kashmir), with a combined annual installed capacity of 15,120 MTPA for Technicals and 43,672 MTPA for Formulations.

On the financial front, the company’s revenue from operations stood at ₹1,152.16 crore in fiscal 2024 as compared to ₹1,203.31 crore in the preceding fiscal. Profit after tax surged to ₹61.29 crore in fiscal 2024 from ₹21.55 crore in fiscal 2023.

For the six months ended September 30, 2024, revenue from operations stood at ₹703.46 crore, and profit after tax at ₹65.87 crore.

Equirus Capital and Motilal Oswal Investment Advisors are the book-running lead managers of the issue.